Log In
Print
BCIQ
Print
Print this Print this
 

Festinavir (OBP-601)

  Manage Alerts
Collapse Summary General Information
Company Oncolys BioPharma Inc.
DescriptionNucleoside reverse transcriptase inhibitor (NRTI)
Molecular Target HIV reverse transcriptase
Mechanism of ActionNucleoside analog polymerase inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationHIV / AIDS
Indication DetailsTreat HIV infection/AIDS
Regulatory Designation

Partner

Bristol-Myers Squibb Co.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today